Generation of Stra8-Cre/ERT2 Mouse Activator Strain for Inducible Cre-lox Recombination in Spermatocytes

View at publisher Summarise with VIRAT
Authors: Leonid A. Ilchuk, Marina V. Kubekina, Yu. D. Okulova, Eugenii N. Korshunov, М. А. Филатов, Alexandra V. Bruter, Yu. Yu. Silaeva
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Reverse genetics often requires systems that allow intended induction of toxic genes or inactivation of vital genes at a chosen moment and/or in a chosen tissue. Cre-lox recombination is a common tool of genetic engineering and is used to conditionally knock out a gene, in which an exon is preliminarily flanked with loxP sites, or to induce expression of a gene, in which a loxP-flanked STOP cassette is preliminarily inserted between the promoter and the open reading frame. A mouse strain, Stra8-Cre/ERT2, was constructed to allow tamoxifen induction of Cre-lox recombination in spermatocytes. Construction was performed using a 400-bp promoter of the Stra8 gene, whose protein product STRA8 initiates the transition from mitosis to meiosis in response to a growing concentration of retinoic acid in the cell. The strain will be further used to study the regulatory mechanisms of meiosis.

Fields of Study & Subjects

Animal Genetics and Reproduction Sperm and Testicular Function Reproductive Biology and Fertility

Publication details

Journal / source
Doklady Biological Sciences
Volume
526
Issue
1
Pages
20–23
Publication date
1 February 2026
Language
EN